Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SlimTide is a metabolic health and wellness company that provides gut-microbiome-targeted supplements and personalized weight management programs. The company's flagship product is a synbiotic supplement containing prebiotic fibers and a specialized probiotic blend, including Akkermansia muciniphila, designed to support metabolic function and appetite regulation. Additionally, through its Slimtides Solutions division, the company offers clinical weight loss programs that incorporate peptide therapies such as semaglutide and tirzepatide alongside health coaching. Led by medical experts like Dr. William Seeds, SlimTide focuses on the intersection of cellular medicine, the gut-brain axis, and sustainable weight management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SlimTide.